Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design
Pharmaceutics · 10.07.2023 · 15 (7) · 1916
DOI: 10.3390/pharmaceutics15071916 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 10.07.2023. Verfasst von Lalitkumar K Vora und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK. Die Arbeit wurde bisher 1029-mal zitiert (Crossref) und nennt 242 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Artificial intelligence (AI) has emerged as a powerful tool that harnesses anthropomorphic knowledge and provides expedited solutions to complex challenges. Remarkable advancements in AI technology and machine learning present a transformative opportunity in the drug discovery, formulation, and testing of pharmaceutical dosage forms. By utilizing AI algorithms that analyze extensive biological data, including genomics and proteomics, researchers can identify disease-associated targets and predict their interactions with potential drug candidates. This enables a more efficient and targeted approach to drug discovery, thereby increasing the likelihood of successful drug approvals. Furthermore, AI can contribute to reducing development costs by optimizing research and development processes. Machine learning algorithms assist in experimental design and can predict the pharmacokinetics and toxicity of drug candidates. This capability enables the prioritization and optimization of lead compounds, reducing the need for extensive and costly animal testing. Personalized medicine approaches can be facilitated through AI algorithms that analyze real-world patient data, leading to more effective treatment outcomes and improved patient adherence. This comprehensive review explores the wide-ranging applications of AI in drug discovery, drug delivery dosage form designs, process optimization, testing, and pharmacokinetics/pharmacodynamics (PK/PD) studies. This review provides an overview of various AI-based approaches utilized in pharmaceutical technology, highlighting their benefits and drawbacks. Nevertheless, the continued investment in and exploration of AI in the pharmaceutical industry offer exciting prospects for enhancing drug development processes and patient care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK.
- Department of Pharmaceutics, St. John Institute of Pharmacy and Research, Palghar 401404, Maharashtra, India.
- Department of Pharmaceutics and Pharmaceutical Technology, L. M. College of Pharmacy, Ahmedabad 380009, Gujarat, India.
- Ph.D. Section, Gujarat Technological University, Ahmedabad 382424, Gujarat, India.
- Pharmacy Section, L. M. College of Pharmacy, Ahmedabad 380009, Gujarat, India.
ORCID-Profile: Lalitkumar K Vora, Amol D Gholap, Keshava Jetha, Raghu Raj Singh Thakur, Vivek P Chavda
Zitieren
APA
Vora, L. K., Gholap, A. D., Jetha, K., Thakur, R. R. S., Solanki, H. K., & Chavda, V. P. (2023). Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design. Pharmaceutics, 15(7), 1916. https://doi.org/10.3390/pharmaceutics15071916
Vancouver
Vora LK, Gholap AD, Jetha K, Thakur RRS, Solanki HK, Chavda VP. Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design. Pharmaceutics. 2023;15(7):1916. doi:10.3390/pharmaceutics15071916
BibTeX
@article{Vora2023,
author = {Vora, Lalitkumar K and Gholap, Amol D and Jetha, Keshava and Thakur, Raghu Raj Singh and Solanki, Hetvi K and Chavda, Vivek P},
title = {Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {7},
pages = {1916},
doi = {10.3390/pharmaceutics15071916}
}
EUVIMED